MAP3K4 antisense RNA 1 (MAP3K4-AS1)

MAP3K4 antisense RNA 1 (MAP3K4-AS1) is a long non-coding RNA transcript that is transcribed in the antisense direction relative to the MAP3K4 gene. Like other antisense RNAs, MAP3K4-AS1 is not translated into protein but is involved in modulating the expression of its sense partner gene (MAP3K4) and potentially nearby or functionally related genes, possibly through cis- or trans-acting mechanisms such as chromatin modification, transcriptional interference, or RNA:mRNA interactions. MAP3K4-AS1 is implicated in the modulation of immune-related gene sets in breast cancer and may act as a molecular biomarker due to its association with distinct molecular subtypes. Currently, there is no direct evidence that MAP3K4-AS1 serves as a drug target, nor are there any drugs developed against it, but its regulatory and biomarker roles are of interest in cancer biology. Key distinguishing points: - This gene is a non-coding RNA, not a receptor, enzyme, or classical druggable target. - Its main function involves the regulation of gene expression, likely of the MAP3K4 gene and possibly in broader immunological and oncology contexts. - It is most relevant as a potential lncRNA biomarker in cancer, rather than as a direct therapeutic target. - There are no known drugs or mechanisms of action involving direct targeting of MAP3K4-AS1, though antisense RNAs in general are subjects for possible future RNA-targeted therapeutics.

Other names

MAP3K4-AS1MAP3K4 Antisense RNA 1